Skip to content

13F-HR filed by Redmile Group, LLC

Redmile Group, LLC filed this 13F-HR for the quarter ended 2015-03-31, filed 2015-05-18, with 54 holding rows worth $1,113,749,000.

Accession
0001425738-15-000014
Filed
2015-05-18
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2015

A holdings report, 54 entries on the cover page, a total value of $1,113,749,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,113,749,000 with VALUE read as thousands by filing date, 13F file number 028-12776. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ARRAY BIOPHARMA INC COM04269X105Stock13,125,594$96,736,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM900,879$66,872,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM5,832,228$63,455,000thousands by filing date
VALEANT PHARMACEUTICALS INTL91911K102COM268,519$53,333,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR853,973$53,203,000thousands by filing date
ENDO INTL PLCG30401106SHS560,443$50,272,000thousands by filing date
AUSPEX PHARMACE05211J102Common Stock417,533$41,866,000thousands by filing date
BIOGEN INC COM09062X103Stock97,713$41,258,000thousands by filing date
SEATTLE GENETICS INC812578102COM1,052,666$37,212,000thousands by filing date
ALERE INC01449J105COM664,138$32,476,000thousands by filing date
CHIMERIX INC COM16934W106Stock844,456$31,828,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock1,381,828$28,742,000thousands by filing date
RECEPTOS, INC.756207106COMMON STOCK159,413$26,286,000thousands by filing date
STANDARD BIOTOOLS INC34385P108COM562,437$23,679,000thousands by filing date
AETNA INC NEW00817Y108COM211,974$22,582,000thousands by filing date
DAVITA INC COM23918K108Stock265,858$21,609,000thousands by filing date
HEALTHWAYS INC422245100COM1,074,033$21,158,000thousands by filing date
ULTRAGENYX PHARMACEUTICAL IN90400D108COM332,600$20,651,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS1,415,482$19,930,000thousands by filing date
CIVITAS SOLUTIONS INC17887R102COM879,485$18,416,000thousands by filing date
CASTLIGHT HEALTH INC CL B14862Q100Stock2,336,498$18,131,000thousands by filing date
MODEL N INC607525102COM1,461,678$17,482,000thousands by filing date
JAZZ PHARMACEUTICALS PLC SHS USDG50871105Stock100,000$17,279,000thousands by filing date
ZS PHARMA INC98979G105Common Stock405,688$17,071,000thousands by filing date
AVALANCHE BIOT05337G107Common Stock421,133$17,064,000thousands by filing date
VCA ANTECH INC918194101COM307,804$16,874,000thousands by filing date
TRIVASCULAR TECHNOLOGIES INC89685A102COM1,588,623$16,665,000thousands by filing date
PROQR THERAPEUTICS NVN71542109SHS EURO751,171$16,436,000thousands by filing date
Lowes Companies Inc42222G108LOW270,358$16,354,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK668,671$15,968,000thousands by filing date
GLOBUS MED INC CL A379577208Stock611,731$15,440,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B103COM547,000$15,245,000thousands by filing date
ACCURAY INC DEL004397105COM1,515,475$14,094,000thousands by filing date
TEKMIRA PHARMACEUTICALS COR87911B209COM NEW700,000$12,222,000thousands by filing date
KYTHERA BIOPHARMACEUTICALS I501570105COM225,062$11,287,000thousands by filing date
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock265,205$11,025,000thousands by filing date
NANOSTRING TECHNOLOGIES INC63009R109COM1,077,642$10,981,000thousands by filing date
INVITAE CORP46185L103COM785,131$10,946,000thousands by filing date
GW PHARMACEUTICALS PLC36197T103ADS119,114$10,855,000thousands by filing date
GENOCEA BIOSCIENCES INC372427104COM796,900$9,451,000thousands by filing date
BELLICUM PHARMACEUTICALS INC079481107COM445,221$9,284,000thousands by filing date
NUVASIVE INC670704105COM185,137$8,514,000thousands by filing date
CERUS CORP157085101COM1,647,727$6,871,000thousands by filing date
BIOSCRIP INC09069N108COM1,378,200$6,105,000thousands by filing date
ARRAY BIOPHARMA INC04269XAA3NOTE 3.000% 6/04,000,000$5,022,000thousands by filing dateprincipal
FLEXION THERAPEUTICS INC33938J106COM189,624$4,270,000thousands by filing date
ACHAOGEN INC004449104COM398,340$3,888,000thousands by filing date
OTONOMY INC68906L105COM78,972$2,792,000thousands by filing date
SESEN BIO, INC.286221106COM240,000$2,141,000thousands by filing date
ISHARES TR464288828US HLTHCR PR ETF8,599$1,144,000thousands by filing date
MARKET VECTORS PHARM ETF T57060U217ETF6,500$457,000thousands by filing date
PowerShares QQQ Trust Unit Ser73935A104COM4,300$454,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM1,390$241,000thousands by filing date
CHEMOCENTRYX INC16383L106COM17,500$132,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001425738-15-000014this filing2015-05-18acceptance time not in the bulk data set